Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Demonstration Project for Identifying Individuals at High-Risk for Chronic Kidney Disease in the United States, Request for Applications (RFA) DP 06-004, 35434 [E6-9647]

Download as PDF 35434 Federal Register / Vol. 71, No. 118 / Tuesday, June 20, 2006 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Demonstration Project for Identifying Individuals at High-Risk for Chronic Kidney Disease in the United States, Request for Applications (RFA) DP 06– 004 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: National Mesothelioma Virtual Registry and Tissue Bank, Request for Applications (RFA) OH–06–005; Occupational Health and Safety Research, Program Announcement (PA) 04–038; and Career Development Grants in Occupational Health and Safety Research, PA 04–105 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the Following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Demonstration Project for Identifying Individuals at High-Risk for Chronic Kidney Disease in the United States, RFA DP 06–004. Time and Date: 1 p.m.–3 p.m., July 31, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘Demonstration Project for Identifying Individuals at High-Risk for Chronic Kidney Disease in the United States,’’ RFA DP 06–004. For Further Information Contact: J. Felix Rogers, Ph.D., M.P.H., Scientific Review Administrator, Office of Extramural Research, CDC, 4770 Buford Highway NE. Mailstop K–92, Atlanta, GA 30341, Telephone 770.488.6521. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. rwilkins on PROD1PC63 with NOTICES Dated: June 14, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–9647 Filed 6–19–06; 8:45 am] BILLING CODE 4163–18–P VerDate Aug<31>2005 17:31 Jun 19, 2006 Jkt 208001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: National Mesothelioma Virtual Registry and Tissue Bank, Request for Applications (RFA) OH–06–005; Occupational Health and Safety Research, PA 04–038; and Career Development Grants in Occupational Health and Safety Research, PA 04–105. Time and Date: 1 p.m.—5 p.m., July 5, 2006 (Closed). Place: Teleconference originating from the office of Dr. Charles Rafferty, 2400 Century Parkway, NE., Room 4306, Atlanta, GA 30345. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of research grants in response to ‘‘National Mesothelioma Virtual Registry and Tissue Bank,’’ Request for Applications (RFA) OH–06–005; ‘‘Occupational Health and Safety Research,’’ PA 04–038; and ‘‘Career Development Grants in Occupational Health and Safety Research,’’ PA 04–105. For Further Information Contact: Charles N. Rafferty, Ph.D., Scientific Review Administrator, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E–74, Atlanta, Georgia 30333, phone (404) 498–2582. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 Dated: June 13, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–9648 Filed 6–19–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Amendment of February 4, 2004, Order to Embargo Birds and Bird Products Imported From Djibouti SUMMARY: On February 4, 2004, the Centers for Disease Control and Prevention (CDC) within the U.S. Department of Health and Human Services issued an order to ban immediately the import of all birds (Class: Aves) from specified countries, subject to limited exemptions for returning pet birds of U.S. origin and certain processed bird-derived products. HHS/CDC took this step because birds from these countries potentially can infect humans with avian influenza (influenza A/[H5N1]). The February 4, 2004, order complemented a similar action taken at the same time by the Animal and Plant Health Inspection Service (APHIS) within the U.S. Department of Agriculture (USDA). On March 10, 2004, HHS/CDC lifted the embargo of birds and bird products from the Hong Kong Special Administrative Region (HKSAR) because of the documented publichealth and animal health measures taken by Hong Kong officials to prevent spread of the outbreak within the HKSAR, and the absence of highly pathogenic avian influenza H5N1 cases in Hong Kong’s domestic and wild bird populations. USDA/APHIS took a similar action. On September 28, 2004, HHS/CDC extended the embargo on birds and bird products to include Malaysia because of the documented cases of highly pathogenic avian influenza A H5N1 in poultry in Malaysia. On July 20, 2005, USDA/ APHIS adopted as a final rule the interim rule that became effective on February 4, 2004, which amended its regulations to prohibit or restrict the importation of birds, poultry, and unprocessed birds and poultry products from regions that have reported the presence of highly pathogenic avian influenza H5N1 in poultry. (See 70 FR 41608 [July 20, 2005].) As the United Nations Food and Agriculture Organization and the World E:\FR\FM\20JNN1.SGM 20JNN1

Agencies

[Federal Register Volume 71, Number 118 (Tuesday, June 20, 2006)]
[Notices]
[Page 35434]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9647]



[[Page 35434]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): Demonstration Project for Identifying 
Individuals at High-Risk for Chronic Kidney Disease in the United 
States, Request for Applications (RFA) DP 06-004

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the Following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Demonstration Project for Identifying 
Individuals at High-Risk for Chronic Kidney Disease in the United 
States, RFA DP 06-004.
    Time and Date: 1 p.m.-3 p.m., July 31, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
``Demonstration Project for Identifying Individuals at High-Risk for 
Chronic Kidney Disease in the United States,'' RFA DP 06-004.
    For Further Information Contact: J. Felix Rogers, Ph.D., M.P.H., 
Scientific Review Administrator, Office of Extramural Research, CDC, 
4770 Buford Highway NE. Mailstop K-92, Atlanta, GA 30341, Telephone 
770.488.6521.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 14, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-9647 Filed 6-19-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.